EAST HANOVER, N.J., June 1, 2021 /PRNewswire/ — Novartis, a leader in immuno-dermatology and rheumatology, today announced the U.S. Food and Drug Administration (FDA) has approved Cosentyx (R) ...
These figures underscore a significant growth trajectory for the Dual Chamber Prefilled Syringes Market, reflecting growing demand for advanced drug delivery systems, especially in biologics, vaccines ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果